Prediction of adverse pathology in prostate cancer using a multimodal deep learning approach based on [<sup>18</sup>F]PSMA-1007 PET/CT and multiparametric MRI.
Lin H, Yao F, Yi X, Yuan Y, Xu J, Chen L, Wang H, Zhuang Y, Lin Q, Xue Y, Yang Y, Pan Z
Lin H, Yao F, Yi X, Yuan Y, Xu J, Chen L, Wang H, Zhuang Y, Lin Q, Xue Y, Yang Y, Pan Z
Li ZY, Wu SN, Lin P, Jiang MC, Chen C, Lin WJ, Xue ES, Liang RX, Lin ZH
Ma L, Jiang X, Yang X, Wang M, Hou Z, Zhang J, Li D
Qu J, Huang D, Shi Y, Liu J, Tang W
Adamson PM, Desai AD, Dominic J, Varma M, Bluethgen C, Wood JP, Syed AB, Boutin RD, Stevens KJ, Vasanawala S, Pauly JM, Gunel B, Chaudhari AS
Wang H, Qiao X, Ding W, Chen G, Miao Y, Guo R, Zhu X, Cheng Z, Xu J, Li B, Huang Q
Kim D, Choo K, Lee S, Kang S, Yun M, Yang J
Wu Y, Zhao T, Hu S, Wu Q, Chen Y, Huang X, Zheng Z
Yuan M, Jie B, Han R, Wang J, Zhang Y, Li Z, Zhu J, Zhang R, He Y
Deng T, Feng J, Le X, Xia Y, Shi F, Yu F, Zhan Y, Liu X, Li C
Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.
We respect your privacy. Unsubscribe at any time.